{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:50:55Z","timestamp":1793429455269,"version":"4.5.0"},"reference-count":45,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.3201\/eid3102.241300","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T14:01:42Z","timestamp":1736517702000},"source":"Crossref","is-referenced-by-count":23,"title":["Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine\u2013Naive Persons after JYNNEOS Vaccination"],"prefix":"10.3201","volume":"31","author":[{"given":"Kara","family":"Phipps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Bialosuknia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Alan P.","family":"DuPuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3102.241300-202501101306-R1","article-title":"Mpox: the reemergence of an old disease and inequities.","author":"Thornhill","year":"2023","journal-title":"Annu Rev Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S0140-6736(24)01751-3","article-title":"Mpox declared a public health emergency.","volume":"404","author":"Adepoju","year":"2024","journal-title":"Lancet"},{"key":"key-10.3201\/eid3102.241300-202501101306-R3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-neutralizing and protective human antibody specificities to poxvirus infections.","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"key-10.3201\/eid3102.241300-202501101306-R4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox.","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R5","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1016\/j.vaccine.2009.07.103","article-title":"Smallpox vaccines for biodefense.","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3102.241300-202501101306-R6","unstructured":"US Food and Drug Administration. FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox. 2019 [cited 2024 Aug 28]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox"},{"key":"key-10.3201\/eid3102.241300-202501101306-R7","unstructured":"European Medicines Agency. EMA recommends approval of Imvanex for the prevention of monkeypox disease. 2022 [cited 2024 Aug 28]. https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-imvanex-prevention-monkeypox-disease"},{"key":"key-10.3201\/eid3102.241300-202501101306-R8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study\u2014United States, August 19, 2022\u2013March 31, 2023.","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3102.241300-202501101306-R9","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States.","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.15585\/mmwr.mm7320a3","article-title":"Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine\u2014United States, May 2022\u2013May 2024.","volume":"73","author":"Guagliardo","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3102.241300-202501101306-R11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed mpox infection\u2014New York, 2022.","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3102.241300-202501101306-R12","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cell.2024.02.003","article-title":"Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic.","volume":"187","author":"Paredes","year":"2024","journal-title":"Cell"},{"key":"key-10.3201\/eid3102.241300-202501101306-R13","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox.","volume":"381","author":"Pittman","year":"2019","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R14","unstructured":"US Food and Drug Administration. JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) [package insert]. 2023 [cited 2024 Aug 28]. https:\/\/www.fda.gov\/media\/131078\/download"},{"key":"key-10.3201\/eid3102.241300-202501101306-R15","doi-asserted-by":"publisher","first-page":"e29134","DOI":"10.1002\/jmv.29134","article-title":"Development of a novel serological assay for the detection of mpox infection in vaccinated populations.","volume":"95","author":"Yates","year":"2023","journal-title":"J Med Virol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R16","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R17","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(23)00352-3","article-title":"Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.","volume":"23","author":"Cohn","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/infdis\/jiaa673","article-title":"Neutralizing antibody responses in COVID-19 convalescent sera.","volume":"223","author":"Lee","year":"2021","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R19","unstructured":"Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Lennette EH, Lennette D, Lennette E, editors. Diagnostic procedures for viral, rickettsial, and chlamydial infections. Washington: American Public Health Association; 1995. p. 189\u2013212."},{"key":"key-10.3201\/eid3102.241300-202501101306-R20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4049\/jimmunol.88.3.339","article-title":"Virus particle aggregation and the plaque-forming unit.","volume":"88","author":"Galasso","year":"1962","journal-title":"J Immunol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R21","first-page":"101","article-title":"Growing poxviruses and determining virus titer.","volume":"269","author":"Kotwal","year":"2004","journal-title":"Methods Mol Biol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity.","volume":"23","author":"Burton","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/v14020438","article-title":"Viral aggregation: the knowns and unknowns.","volume":"14","author":"Pradhan","year":"2022","journal-title":"Viruses"},{"key":"key-10.3201\/eid3102.241300-202501101306-R24","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1016\/j.vaccine.2022.10.078","article-title":"Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.","volume":"40","author":"Priyamvada","year":"2022","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3102.241300-202501101306-R25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.chom.2023.05.001","article-title":"Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.","volume":"31","author":"Hubert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"key-10.3201\/eid3102.241300-202501101306-R26","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1016\/S1473-3099(23)00571-6","article-title":"Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis.","volume":"23","author":"Moschetta","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R27","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jama.2024.20951","article-title":"Decline of mpox antibody responses after modified vaccinia Ankara\u2013Bavarian Nordic Vaccination.","volume":"332","author":"Collier","year":"2024","journal-title":"JAMA"},{"key":"key-10.3201\/eid3102.241300-202501101306-R28","doi-asserted-by":"publisher","first-page":"106309","DOI":"10.1016\/j.jinf.2024.106309","article-title":"Mpox Immune response elicited by MVA-BN vaccine over 12 months of follow-up.","volume":"89","author":"Matusali","year":"2024","journal-title":"J Infect"},{"key":"key-10.3201\/eid3102.241300-202501101306-R29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R30","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1128\/JCM.41.7.3154-3157.2003","article-title":"Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.","volume":"41","author":"Newman","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R31","doi-asserted-by":"publisher","first-page":"2400575","DOI":"10.2807\/1560-7917.ES.2024.29.38.2400575","article-title":"Orthopoxvirus-specific antibodies wane to undetectable levels 1\u202fyear after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.","volume":"29","author":"van Leeuwen","year":"2024","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3102.241300-202501101306-R32","doi-asserted-by":"publisher","first-page":"5.12.1","DOI":"10.1002\/cpps.34","article-title":"Preparation of cell cultures and vaccinia virus stocks.","volume":"89","author":"Cotter","year":"2017","journal-title":"Curr Protoc Protein Sci."},{"key":"key-10.3201\/eid3102.241300-202501101306-R33","doi-asserted-by":"publisher","first-page":"e29407","DOI":"10.1002\/jmv.29407","article-title":"Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak.","volume":"96","author":"Asquith","year":"2024","journal-title":"J Med Virol"},{"key":"key-10.3201\/eid3102.241300-202501101306-R34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study.","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"key-10.3201\/eid3102.241300-202501101306-R36","doi-asserted-by":"publisher","first-page":"126409","DOI":"10.1016\/j.vaccine.2024.126409","article-title":"MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings.","volume":"42","author":"Mason","year":"2024","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3102.241300-202501101306-R37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.3201\/eid3010.240292","article-title":"Mpox epidemiology and vaccine effectiveness, England, 2023.","volume":"30","author":"Charles","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.15585\/mmwr.mm7233a3","article-title":"Epidemiologic and clinical features of mpox in adults aged >50 years\u2014United States, May 2022\u2013May 2023.","volume":"72","author":"Eustaquio","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3102.241300-202501101306-R39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/sextrans-2023-056055","article-title":"Mpox after vaccination: a case series.","volume":"100","author":"Apar\u00edcio Martins","year":"2024","journal-title":"Sex Transm Infect"},{"key":"key-10.3201\/eid3102.241300-202501101306-R40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series.","volume":"24","author":"Hazra","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R41","unstructured":"United States Food and Drug Administration. ACAM2000: smallpox vaccine. Vaccines and Related Biological Products Advisory Committee (VRBPAC) briefing document. 2007 Apr 18 [cited 2024 Aug 28]. https:\/\/wayback.archive-it.org\/7993\/20170405044400\/https:\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4292B2-02.pdf"},{"key":"key-10.3201\/eid3102.241300-202501101306-R42","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/infdis\/jiac455","article-title":"One- and two-dose vaccinations with modified vaccinia Ankara\u2013Bavarian Nordic induce durable B-cell memory responses comparable to replicating smallpox vaccines.","volume":"227","author":"Ilchmann","year":"2023","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3102.241300-202501101306-R43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"key":"key-10.3201\/eid3102.241300-202501101306-R44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"key":"key-10.3201\/eid3102.241300-202501101306-R45","doi-asserted-by":"publisher","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","article-title":"Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques.","volume":"16","author":"Jacob-Dolan","year":"2024","journal-title":"Sci Transl Med"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T14:01:44Z","timestamp":1736517704000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/31\/2\/24-1300_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3102.241300","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}